Submit RFI/RFP
Request Consultation
Pharmacovigilance Requirements in Russia
Pharmacovigilance (PV) in Russia is a critical component of the national healthcare system, designed to ensure the safety, efficacy, and quality of medicines throughout their lifecycle. Governed by…
Insights
Blogs
56 articles
RMP, Requirements & Compliance: Europe vs KSA
In today’s global pharmaceutical landscape, Risk Management Plans (RMPs) are cornerstone documents ensuring that the benefits of medicinal products outweigh their risks. They serve as living frameworks for…
Local Safety Databases: A Global Overview
In pharmacovigilance, Local Safety Databases (LSDs) are critical for ensuring continuous monitoring of drug safety within specific countries or regions. While the WHO’s VigiBase serves as a global…
Pharmacovigilance requirements in China
Pharmacovigilance (PV) in China refers to the scientific and regulatory activities related to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problems. The…
PV Requirements in Latin American Countries
PV Requirements in Latin American Countries (Brazil, Mexico, Argentina, Chile, and Colombia) Introduction Medicines don’t stop being monitored once they’re approved—they enter a new phase of oversight known…
PSMF: Europe VS KSA — From Initiation to Perfection
The Pharmacovigilance System Master File (PSMF) serves as a cornerstone document within pharmacovigilance systems, providing a detailed overview of a company’s PV activities and organizational structures. While the…
Pharmacovigilance requirements in Greece
In Greece, pharmacovigilance (PV) activities are regulated and supervised by the National Organization for Medicines (EOF – Εθνικός Οργανισμός Φαρμάκων). The requirements are aligned with EU legislation, but…
AI and Big Data for Safety Signal Detection in Pharmacovigilance
Modern pharmacovigilance monitors the safety of medicines throughout their life‑cycle and is essential for protecting public health. Safety signal detection refers to identifying patterns in data that suggest…
Pharmacovigilance Frameworks – Australia and New Zealand
Although Australia and New Zealand are geographically close-to the point mistakenly considered to be one country-their pharmacovigilance (PV) systems are governed by different frameworks and guidelines. This article…
Difference in QPPV Nomination Between EU and KSA
In the pharmaceutical world, ensuring patient safety is a global priority, and the Qualified Person for Pharmacovigilance (QPPV) plays a central role in this mission. However, regulatory frameworks…
Pharmacoeconomic Studies in KSA
Pharmacoeconomics is rapidly becoming a cornerstone of healthcare decision-making in Saudi Arabia. With the release of the Saudi Food and Drug Authority (SFDA) guidelines on Economic Evaluation Studies…
Ready to simplify your journey?
Talk to our experts and get tailored solutions to help you stay compliant and move forward with confidence.
Submit RFI/RFP